Elevance Health (ELV) Revenue — Quarter Ended Mar 31, 2025
Revenue increased in the reporting quarter. It was higher than both the immediately preceding quarter and the same quarter one year earlier.
Key takeaway
Quarter ended Mar 31, 2025 · FY2025 Q1
Revenue increased in the reporting quarter. It was higher than both the immediately preceding quarter and the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$48.9B
Revenue reported for this quarter.
Quarter-over-quarter
+7.6%
Change from the immediately preceding quarter.
Year-over-year
+14.8%
Change from the comparable year-ago quarter.
Trailing four quarters
$183.3B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2024 | $43.9B | +0.5% |
| Sep 30, 2024 | $45.1B | +5.3% |
| Dec 31, 2024 | $45.4B | +6.6% |
| Mar 31, 2025 | $48.9B | +14.8% |
Revenue performance
The company posted a revenue gain for the quarter. The growth continued the upward trend observed over the trailing year.
Quarterly comparison
Revenue in the current quarter exceeded the prior quarter's figure. Revenue also surpassed the level from the same period a year ago.
What to watch
The rate of revenue growth accelerated in the most recent quarter relative to earlier quarters in the trailing period.